In this issue of the Journal, Thabut and colleagues embark on a large multicenter audit
in France, wherein they analyze the application of early transjugular intrahepatic portosystemic shunt (TIPS), defined as intervention within 72 hours of the index endoscopy, for portal hypertension (PHT) related bleeding. [1] Their study demonstrates that of 35% of patients meeting current eligibility criteria for early TIPS (namely, Child C cirrhosis <13 points or Child B with active bleeding at endoscopy) [2] , in 'real life', barely 7% of patients received this intervention. Furthermore, in these limited numbers of patients receiving early TIPS, most had less advanced disease and therefore a lower risk of bleeding mortality. Whilst the lack of technical availability was mooted as a potential reason, it transpires that over one-third of centers had daily feasibility to perform TIPS, although feasibility and actually being capable of delivering are two separate issues. Consequently, it is perhaps unsurprising that on multivariate analysis, early TIPS failed to show any proven benefit in this population and the only independent risk factor associated with survival in this study was severity of liver disease.
In a recent meta-analysis of four studies that were designed specifically to address the role of early TIPS, [3] two studies, both randomised, showed a significant increase in survival, albeit, neither was designed to assess survival as a primary endpoint. [2, 4] The other two studies did not find a statistically significant increase in survival, with one including patients with Child-Pugh score to 15 points and thereby, very advanced disease. [5, 6] The overall finding of the meta-analysis did suggest that early TIPS increased control of bleeding, decreased rate of re-bleeding and did increase survival. This was further supported by a recent large retrospective study from the US, where early TIPS improved mortality and reduced re-bleeding with no appreciable increase in the incidence of hepatic encephalopathy, and a similar retrospective European study. [7, 8] One of the features of PHT-related bleeding is the relationship with a systemic inflammatory response and increased gut bacterial translocation, which may further aggravate organ dysfunction and precipitate the onset of acute-on-chronic liver failure. [9] In this regard, a potential explanation for reduced mortality after TIPS is the immediate reduction in portal hypertension and associated pathophysiology, which facilitates reduced gut bacterial translocation and the related systemic inflammatory response. This has been demonstrated by data showing a reduction in endotoxin and TNF receptor levels post elective TIPS [8] , as well as reduced levels of chemokines such as CXCL9. [10, 11] A potential weakness in the study described by Thabut and colleagues [1] is that no data was recorded on other morbidity factors, including hepatic encephalopathy, or progression of liver decompensation, nor re-bleeding events. It would have been interesting to note post-TIPS, whether the model for end-stage liver disease (MELD) score or level of hepatic decompensation progressed further in these patients longer term. Also of note is that in patients with refractory bleeding, six-week mortality was 18% compared to 9% in the early TIPS group (p = 0.32), and refractory bleed patients had much higher baseline Child-Pugh (10.7 vs. 8.9) and MELD (20 vs. 16) scores, and presentation with encephalopathy (45% vs. 15%). This underlies the limitation of use of Child-Pugh or MELD scores alone to define the 'high-risk' group who may have the biggest mortality benefit from early TIPS, in part, since some of their components such as ascites and creatinine may improve post-TIPS, whilst other factors such as bilirubin and encephalopathy, may progress. Indeed, liver failure after TIPS may occur in up to 10% cases, despite an MELD <12. [12] A seminal randomised study by Monescillo et al. demonstrated that in 116 patients in whom the hepatic venous pressure gradient (HVPG) was performed within 24 hours of an acute variceal bleed, failure to control bleeding and one-year mortality were associated with HVPG >20 mmHg, and that early TIPS reduced treatment failure and mortality. [4] This suggested that haemodynamic factors may define a high-risk group, though clearly HVPG measurement during an index bleed is impractical. It remains to be established whether other surrogates of portal hypertension, such as Fibroscan or real-time shear wave technology, or even platelet count, can be used to predict hepatic dysfunction and optimal candidates for early TIPS. [13] Similarly, it is possible that reduced markers of systemic inflammatory response may predict beneficial response and survival after TIPS, as has been suggested for the chemokine, CXCL11. [14] .
The study reported by Thabut et al. shows the mean delay to TIPS placement was 1.9 ± 0.8 days, albeit the median delay till TIPS was 3.4 (2.6-4.4) days. This could suggest that the apparent control of bleeding at index endoscopy makes physicians reluctant to pre-emptively use TIPS in patients within 72 hours of the index bleed. If so, what might be their concern? A lack of confidence in current data on improved control of bleeding and survival may be inferred from this study, though other concerns may exist on precipitation of hepatic encephalopathy or worsening of liver function, in patients in whom bleeding is controlled. Of note, at the start of the audit only eight centers included early TIPS in their local bleeding guidelines, despite the then Baveno V guidelines [15] ; a reflective questionnaire as a follow on to this audit showed that <15% changed their practice despite the subsequent Baveno VI recommendations, and as a refection of this, there was no increase in TIPS service provision. [16] Furthermore, most responders continued to hold an opinion that evidence for early TIPS remained weak, as shown by the mean questionnaire response addressing this question of 4.43 out of a linear scale from 1 to 10.
Thabut et al. [1] also found that many of the non-academic centers used considerably fewer vaso-active drugs, perhaps suggesting sub-optimal medical therapy was applied before a decision on TIPS requirement was undertaken. This would also influence the requirement for TIPS, if based on endoscopic signs of active bleeding at first endoscopy, even if less severe liver disease was present. Indeed, we learn that there was a higher proportion of active bleeding at endoscopy in non- An area of on-going debate exists as to the cut-off for liver disease severity (most often capped at Child-Pugh score C-13), where perceived benefit from early TIPS is perhaps out-weighed by poor survival in those with advanced disease. [6] This is thought to relate to impaired liver perfusion after TIPS and the associated risk of liver failure in such decompensated patients. In decompensated patients, placement of TIPS may facilitate an opportunity to list and bridge patients, who had not previously been identified before an index bleed, to liver transplantation over a shorter time frame.
Whilst it is clear that patients with more stable Child A and B cirrhosis generally have good outcomes, as seen by Thabut and colleagues, further randomised studies are clearly needed, specifically in Child C patients, to assess whether there is a ceiling of severity at which TIPS fails to improve outcomes.
In summary, the study by Thabut et al. in this issue of the Journal highlights the 'real life' difficulties in adherence to clinical guidelines such as Baveno VI, when physician bias may preclude deployment of an intervention, that indeed may have the potential to significantly improve outcomes in PHT-related bleeding. More prospective randomised studies demonstrating the benefit of early TIPS will undoubtedly help improve adherence to bleeding guidelines. This needs to be coupled with better access to out-of-hours TIPS services.
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